| 000 | 01836 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517070159.0 | ||
| 264 | 0 | _c20160829 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1778-3585 | ||
| 024 | 7 |
_a10.1016/j.eurpsy.2015.10.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVolavka, J | |
| 245 | 0 | 0 |
_aHostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studies. _h[electronic resource] |
| 260 |
_bEuropean psychiatry : the journal of the Association of European Psychiatrists _cJan 2016 |
||
| 300 |
_a13-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBenzodiazepines _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHostility |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMedication Adherence _xpsychology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOlanzapine |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 | _aSchizophrenic Psychology |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aAssessment of Medication Adherence |
| 700 | 1 | _aVan Dorn, R A | |
| 700 | 1 | _aCitrome, L | |
| 700 | 1 | _aKahn, R S | |
| 700 | 1 | _aFleischhacker, W W | |
| 700 | 1 | _aCzobor, P | |
| 773 | 0 |
_tEuropean psychiatry : the journal of the Association of European Psychiatrists _gvol. 31 _gp. 13-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eurpsy.2015.10.003 _zAvailable from publisher's website |
| 999 |
_c25532908 _d25532908 |
||